Veterinary Medicine Information website

Eurican Primo suspensão injetável

Authorised
  • Canine parvovirus, strain 154, Live
Download as PDF

Product identification

Medicine name:
Eurican Primo suspensão injetável
Active substance:
  • Canine parvovirus, strain 154, Live
Target species:
  • Dog (puppy)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain 154, Live
    5.50
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Portugal Unipessoal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • UPD 1.6.1-4 JSON NAP Chpt2 C2 Mandatory 504/93 DGV
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 19/06/2023
Updated on: 25/06/2023
Download